Clinical Trials

A clinical trial is a carefully designed research study that tests whether a new treatment, drug, or approach is safe and whether it works. Trials are how potential ALS/MND treatments are studied before they could ever become widely available. People with ALS/MND who take part are essential to that progress.

An important starting point: a clinical trial is research, not proven treatment. The whole point of a trial is that the answer is not yet known. The treatment being tested may help, may make no difference, or may have side effects. Going in with clear, realistic expectations matters, and this card aims to help you do that.

Why people consider taking part:

• Possible access to a potential new treatment before (and if) it becomes available. There is no guarantee it will help, and some participants receive a comparison or placebo (explained in the next question).
• Contributing to progress. Many people find real meaning in helping research that could benefit others with ALS/MND in the future, whatever the outcome for them.
• Close monitoring. Trials often involve careful, regular assessment by specialists, which some people value.
• A sense of doing something active in the face of the condition.

Why a trial might not be right, or possible:

• Eligibility is often strict, and not everyone qualifies (next questions cover this).
• It can involve extra visits, tests, travel, and time, which is a real consideration when energy is limited.
• There are uncertainties and possible risks, since the treatment is unproven.

Deciding whether to explore a trial is a personal choice, and there is no right answer. Taking part and not taking part are both completely valid. This card explains how trials work, the benefits and risks to weigh, how to find them, what to ask, and how to avoid false hope and scams, so you can decide with good information. The next question looks at how trials actually work.

Understanding how trials are designed helps you know what taking part really involves. A few key ideas come up again and again:

• Phases. Trials happen in stages. Early-phase trials (often smaller) focus mainly on safety and dose; later-phase trials (often larger) test whether the treatment actually works compared with current care. A treatment must usually pass through these phases before it could be approved.
• Control groups and placebo. Many trials compare the new treatment against either a placebo (an inactive substitute) or the current standard treatment, to see if the new one truly makes a difference. This means some participants may not receive the active treatment. That is an important thing to understand before joining.
• Randomisation. To make the comparison fair, participants are often assigned to groups by chance (randomly), rather than by choice.
• Blinding. In many trials, participants do not know who is receiving the active treatment until the end. Sometimes the researchers do not know either. This reduces bias but means you may not know which group you are in.
• Informed consent. Before joining, you receive detailed information and must give consent. This is your opportunity to understand exactly what is involved, ask questions, and decide freely. You can withdraw at any time, for any reason, without affecting your usual care.
• Eligibility criteria. Each trial has specific rules about who can join (for example, based on how long since diagnosis, symptoms, or other factors), to keep it safe and the results meaningful.
• Oversight. Legitimate trials are reviewed and approved by ethics committees and regulators, and follow strict rules to protect participants.

Why these features matter to you: they explain why you might receive a placebo, why you may not get to choose your group, and why eligibility can be strict. None of these mean anything is wrong. They are how trials produce trustworthy answers.

Knowing this helps you ask good questions and set realistic expectations. The next question weighs the potential benefits and risks of taking part.

Deciding about a trial means weighing real but uncertain possible benefits against real costs and risks. There is no universal right answer. It depends on the specific trial and on what matters to you. Here is an honest balance to consider.

Potential benefits:

• Possible early access to a treatment that might help. This is never guaranteed, and may not happen for you.
• Contributing to research that could help others and advance understanding of ALS/MND. This benefit holds true regardless of your personal outcome.
• Close specialist monitoring and attention during the trial.
• A sense of agency. Actively doing something.

Risks and costs to weigh:

• It may not help you. The treatment is unproven; it may not work, and you may receive a placebo or comparison rather than the active treatment.
• Possible side effects. Because the treatment is being studied, not all effects are known, and there may be unexpected ones.
• Burden. Extra appointments, tests, travel, and time can be significant. That is a real cost when energy and time are precious.
• Emotional ups and downs. Hoping a treatment helps, and facing uncertainty or disappointment, can be hard.
• Possible restrictions. Some trials limit other treatments or trials you can have during or after, which is worth understanding.

Holding hope and realism together: it is natural and okay to hope a trial could help you. Hope matters. At the same time, going in with realistic expectations protects you from being crushed if it does not. Both can be true: you can hope, and understand that the main certainty a trial offers is a contribution to knowledge.

This is a personal decision. Take time, talk it through with your ALS/MND team and the people close to you, and choose what feels right for you. Your team can help you think about how a specific trial fits your situation, goals, and energy. The next question covers how to find trials and check eligibility.

There are good ways to find out what trials exist and whether any might suit you. Your ALS/MND team is the best partner in this.

Where to look:

• Your ALS/MND team or neurologist. Usually the best starting point. They will often know about trials you may be eligible for, including at their own or nearby centres, and can advise whether any fit your situation.
• Your MND/ALS association. These often keep information on current trials and can guide you to trustworthy sources and trial-finding help.
• Trial registries and finders. Public databases list registered trials and their eligibility criteria; some associations run ALS/MND-specific trial-matching services. These let you search by condition and location.
• Research registries. Joining one can mean being notified about trials you might suit (see the research registries card).

On eligibility:

• Trials have specific entry criteria. These can include time since diagnosis, symptoms, lung function, other treatments, genetics, or general health. They keep trials safe and meaningful.
• Not qualifying is common and is not a judgement. It is about fitting the study's design.
• Timing can matter. Some trials have windows (for example, within a certain time of diagnosis), so it is worth exploring sooner rather than later if you are interested. There is no obligation.
• Your team can check eligibility and handle referrals to a trial centre.

Practical tips:

• Don't go it alone. Involve your team. They can interpret whether a trial is genuine, suitable, and worthwhile for you.
• Be wary of anything that asks you to pay to take part (covered in the scams question). Legitimate trials do not charge you for the experimental treatment.

Because availability and access vary by country and change over time, your ALS/MND team and association are the most reliable, up-to-date guides for where you live. The next question covers what to ask about a specific trial.

If you are considering a specific trial, asking the trial team thorough questions helps you decide well. A good, ethical trial team will welcome every one of these. Bring someone with you, and take your time. You do not have to decide on the spot.

About the treatment and the study

• What is being tested, and what is already known about its safety and possible effects?
• What phase is the trial, and what is it trying to find out?
• What are the possible benefits? How likely are they, realistically?
• What are the known and possible risks and side effects?

What taking part involves

• Could I receive a placebo or comparison rather than the active treatment, and how likely is that?
• How many visits, tests, and how much travel are involved, and over how long?
• What will be expected of me, and how might it affect my daily life and energy?
• Are there any costs to me, and are travel or other expenses covered? (Be cautious if asked to pay for the treatment itself.)

My care and my rights

• How will this affect my usual ALS/MND care and any other treatments?
• Can I stay on, or restart, my current treatments?
• Can I withdraw at any time, and what happens if I do?
• What happens after the trial ends? Could I keep accessing the treatment if it helps?

Practical and ethical checks

• Who is running and funding the trial, and has it been approved by an ethics committee/regulator?
• Who do I contact during the trial if I have problems or questions?
• How and when will I learn the results?

Before deciding: read the information sheet carefully, discuss it with your ALS/MND team (who can give an independent view on whether it suits you) and your family, and only consent when you understand and feel comfortable. The next question covers protecting yourself from false hope and scams.

A serious diagnosis can make any promise of help deeply tempting. That is exactly why, sadly, some people and clinics exploit it. Wanting hope is completely human and nothing to be ashamed of; this question is about protecting you and your family from being harmed or taken advantage of.

A key rule of thumb: legitimate clinical trials do not charge you for the experimental treatment. If you are asked to pay (often large sums) to receive an unproven treatment, especially outside a properly regulated trial, treat that as a serious warning sign.

Common red flags:

• Paying to take part in a "trial" or to receive an experimental treatment.
• Guaranteed results, cures, or "miracle" claims. Real trials never promise they will work; that is the whole point of testing.
• No proper oversight. No ethics approval, no informed consent process, no published protocol, or unwillingness to involve your own doctors.
• Pressure to decide quickly, or discouragement from getting independent advice.
• Unproven "stem cell" or similar treatments at private clinics, sometimes abroad. This is often called "stem cell tourism". Many are unregulated, unproven, expensive, and can be genuinely dangerous. Legitimate stem-cell research does exist, but it happens within regulated trials. It does not happen in pay-to-access clinics.
• Treatments only available through one clinic, with testimonials instead of evidence.

How to protect yourself:

• Always involve your ALS/MND team. Before paying for or starting any experimental treatment, ask them. They can tell you whether something is legitimate and safe, and they want to help, not judge.
• Check independent sources. Services like ALSUntangled provide independent scientific reviews of treatments and claims people encounter, which can help you evaluate them.
• Be cautious online. Be wary of treatments promoted in social media groups, by sellers, or through testimonials rather than evidence.
• Take your time and seek independent advice. Pressure to act fast is itself a warning sign.

This is not about crushing hope. It is about directing it somewhere safe. Real hope in ALS/MND research is found in legitimate, regulated trials and in your medical team, not in those who would profit from fear. If something feels too good to be true, please check with your team before committing money or your health. The emerging therapies and supplements cards cover evaluating other kinds of treatments and claims.